National Cancer Center Hospital (JPN-001)
National Cancer Center Hospital (JPN-001)
Tokyo, Japan1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation | Cholangiocarcinoma Metastatic; Cholangiocarcinoma Non-resectable | Active, not recruiting | Phase 2 | 2025-12-09 | NCT06081829 |